Results

Total Results: 1,534 records

Showing results for "drug".

81. Clinical Topic (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085textdesc.pdf
    January 01, 2012 - following screenings at the first prenatal visit: screening for depression, alcohol use, tobacco use, drug … visit Tobacco use screening Patients who were screened for tobacco use* at the first visit Drug … use (illicit and prescription, over the counter) screening Patients who were screened for any drug … use, prescription drug use and over the counter drug use. … Illicit, Prescription and Over the Counter Drug Use ScreeningRisk Category/Assessment For the purposes

82. Behavioral Health Risk Assessment for Pregnant Women Measure Technical Specifications (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/0085-tech-specs.pdf
    January 01, 2012 - following screenings at the first prenatal visit: screening for depression, alcohol use, tobacco use, drug … visit Tobacco use screening Patients who were screened for tobacco use* at the first visit Drug … use (illicit and prescription, over the counter) screening Patients who were screened for any drug … use, prescription drug use and over the counter drug use. … Illicit, Prescription and Over the Counter Drug Use ScreeningRisk Category/Assessment For the purposes

83. Declines in Hospital-Acquired Conditions (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data/infographics/hac-rates-2019-updated.pdf
    January 01, 2019 - Hospital- Acquired Conditions National efforts to reduce hospital-acquired conditions such as adverse drug … Adverse Drug Events -28% CAUTI* -5% CLABSI+ -6% Clostridioides difficile Infections -37%

84. Final Progress Report: Risk of Acute Asthma Associated with the Pediatric Use of Opioids (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-02/chen-report.pdf
    January 01, 2024 - Drug Safety and Availability - FDA Drug Safety Communication: FDA Restricts Use of Prescription Codeine … Drug Safety and Availability - FDA Drug Safety Communication: FDA Requires Labeling Changes for Prescription … Drug Safety and Availability - FDA Drug Safety Communication: Safety Review Update of Codeine Use in … Drug Safety and Availability - FDA Drug Safety Communication: FDA Evaluating the Potential Risks of … Drug Safety and Availability - FDA Drug Safety Communication: FDA Evaluating the Risks of Using the

85. Ncinqtobaccousehelp-References (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelp-References.pdf
    August 01, 2012 - CHIP-Program-Information/By-Topic/Early-Periodic-Screening-Diagnosis-Treatment.html National Institute on Drug … Screening for Drug Use in General Medical Settings: A Quick Reference Guide. NIH Pub No. 09-7384. … National Survey on Drug Use and Health (NSDUH). 2010 National Survey on Drug Use and Health data.

86. Fallpxtool3I (doc file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/fallpxtoolkit/fallpxtool3i.docx
    January 01, 2012 - committee or pharmacy department for formulary drugs within the American Hospital Formulary Service drug … adjustment for renal function or disease state, overuse of medications, IV access Laboratory Therapeutic drug

87. From Quality Measures to Quality Care: Examples of Quality Improvement at Work | Agency for Healthcare Research and Quality
    ce.effectivehealthcare.ahrq.gov/patient-safety/quality-measures/21st-century/challenges.html
    June 01, 2018 - Preventing Adverse Drug Reactions Preventable adverse drug events cause significant mortality each … LDS Hospital in Salt Lake City, Utah, has taken steps to improve its rate of adverse drug events. … From 1990 to 1993, they discovered that 2.43 percent of hospital patients experienced an adverse drug … These efforts led to a 75-percent decline in adverse drug reactions related to antibiotics. … information; increased availability of needed medications; and routine monitoring of drug distribution

88. Number of Newborns with Neonatal Abstinence Syndrome Continued To Increase Through 2016 | Agency for Healthcare Research and Quality
    ce.effectivehealthcare.ahrq.gov/data/infographics/neonatal-abstinence-syndrome-2016.html
    July 01, 2019 - Text Description: The number of babies born each year with withdrawal symptoms from their mother’s drug … In 2016, more than 25,000 babies were born with withdrawal symptoms from drug dependence compared with

89. Declines in Hospital-Acquired Conditions | Agency for Healthcare Research and Quality
    ce.effectivehealthcare.ahrq.gov/data/infographics/hac-rates_2019.html
    July 01, 2020 - 11.1 MB) Text Description: National efforts to reduce hospital-acquired conditions such as adverse drug … Specific rates are: Adverse drug events: 28% decrease. CAUTI: 5% decrease. CLABSI: 6% decrease.

90. References (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
    August 12, 2012 - Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associated with attention- deficit hyperactivity disorder (ADHD) drug treatment: a retrospective … Drug Saf; 2009;32(11):1089-1110 McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. … Drug Saf. 2009;32(11):1089-1110 McGoey KE, DuPaul GJ, Haley E, Shelton TL.

91. ADHD Behavior Therapy References (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
    August 12, 2012 - Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associated with attention- deficit hyperactivity disorder (ADHD) drug treatment: a retrospective … Drug Saf; 2009;32(11):1089-1110 McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. … Drug Saf. 2009;32(11):1089-1110 McGoey KE, DuPaul GJ, Haley E, Shelton TL.

92. Identification, Classification, and Frequency of Medical Errors in Outpatient Diabetes Care (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/OConnor.pdf
    November 29, 2004 - Inappropriate or risky drug prescribing occurred in 9.9 percent of the 5,729 patients. … Among the categories of drug-related medical errors are those related to drug-drug interactions, use … dl With drug intensification 159 3.8% LDL ≥ 130 mg/dl No drug intensification 536 12.9% Triglycerides … +Drug-fill date more than 4 weeks after test date. … +Type 1 lipid error is inadequate drug treatment when LDL ranges 100-129 mg/dl.

93. Postdiscalldoc (doc file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/red/toolkit/postdiscalldoc.docx
    February 06, 2013 - phone call: Review: Health history Medicine lists for consistency Medicine list for appropriate dosing, drug-drug … and drug-food interactions, and major side effects Contact sheet DE notes Discharge summary and AHCP … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper … No change needed in discharge plan as it relates to the drug therapy Educated patient/caregiver on proper

94. Prologue: Technology and Medication Safety (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol4/Advances-Prologue_Grady_Vol4.pdf
    July 25, 2008 - are already using health IT in a number of ways: to help prevent medical errors, including adverse drug … Medication errors are a frequent cause of adverse drug events, and they can occur at any point in the … have been proposed and tried over the years to improve medication management and minimize adverse drug … analgesia (PCA), and monitor the medication use of Medicare beneficiaries at high risk of adverse drug … medication therapy management program that included pharmacist visits for seniors at high risk for drug-related

95. 6 Tk1 T5-Suspect A Urinary Tract Infection Brochure Ma Coalition Final (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/nhguide/6_TK1_T5-Suspect_a_Urinary_Tract_Infection_brochure_MA_Coalition_final.pdf
    June 18, 2015 - Sometimes antibiotics can: »Lead to a drug interaction, where one of your medications could become … When resistance occurs, it can be harder to find the right drug to treat an infection.

96. Use of Electronic Health Records | Agency for Healthcare Research and Quality
    ce.effectivehealthcare.ahrq.gov/research/findings/nhqrdr/chartbooks/carecoordination/measure5.html
    June 01, 2018 - Allergy Alerts 79 84.5 Drug-Drug Interaction Alerts 78.3 83.9 Drug-Lab Interaction Alerts … Drug-drug interaction alerts, from 78.3% to 83.9%. … Drug-lab interaction alerts, from 66.6% to 72.7%. Drug dosing support, from 62.9% to 71.8%. … is associated with a 13% to 99% reduction in medication errors and a 30% to 84% reduction in adverse drug … is associated with a 13% to 99% reduction in medication errors and a 30% to 84% reduction in adverse drug

97. Synthetic Healthcare Database for Research Description of Data Elements (Codebook) (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Codebook.pdf
    December 01, 2023 - name General Notes: Generic drug names (GENERIC_DRUG_NAME) were derived from National Drug Classification … (NDC) codes using the mapping in the Multum drug, herbal, and nutraceutical database. … Multum therapeutic class but may not be the original generic drug name. … the data: https://www.cerner.com/solutions/drug-database. … name Up to 50 characters Generic drug name Blank Missing SyH-DR 54 Codebook

98. CHIPRA 212 Appendix 2 (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-appendix-2.pdf
    January 17, 2024 - 2 APPENDIX 2 - INHALED CORTICOSTEROIDS (ICS) ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d05262 DPI 4 and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d01296 DPI 4 and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d04276 DPI 6 and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d00760 MDI 5 and older Y Y N Y ICS NDC Code Brand Name Generic Product Name Route Drug

99. References | Agency for Healthcare Research and Quality
    ce.effectivehealthcare.ahrq.gov/patient-safety/settings/hospital/match/references.html
    July 01, 2022 - The costs of adverse drug events in hospitalized patients. … Adverse Drug Events Prevention Study Group. JAMA 1997; 277(4):307-11. … Identifying hospital admissions due to adverse drug events using a computer-based monitor. … Pharmacoepidemiol Drug Saf 2001;10(2):113-9. The Joint Commission.

100. 5 Tk2 P3T1-Sample Policy Phase 3 (doc file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK2_P3T1-Sample_Policy_Phase_3.doc
     May 01, 2014 - The adverse consequences of inappropriate prescribing practices—including drug reactions/interactions … overuse of newer, broad-spectrum antibiotics when either no antibiotic or an older narrow-spectrum drug